We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+7.88%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$5.51B
AUM Growth
+$99.7M
Cap. Flow
-$170M
Cap. Flow %
-3.09%
Top 10 Hldgs %
18.48%
Holding
1,445
New
336
Increased
635
Reduced
341
Closed
112

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$53.9M
2
PDD icon
Pinduoduo
PDD
+$47.7M
3
LOGC
ContextLogic
LOGC
+$25.5M
4
TDUP icon
ThredUp
TDUP
+$25.1M
5
UPWK icon
Upwork
UPWK
+$24.9M

Top Sells

Rank Stock Value
1
RVLV icon
Revolve Group
RVLV
+$66M
2
NTES icon
NetEase
NTES
+$50.7M
3
TRIP icon
TripAdvisor
TRIP
+$46.2M
4
GRPN icon
Groupon
GRPN
+$44.5M
5
QVCGA
QVC Group Inc Series A
QVCGA
+$43.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 30%
2 Technology 24.74%
3 Communication Services 13.13%
4 Financials 5.61%
5 Industrials 4.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMGN
1101
DELISTED
Immunogen Inc
IMGN
$29K ﹤0.01%
4,550
+135
+3% +$942
LAD icon
1102
Lithia Motors
LAD
$8.26B
$28K ﹤0.01%
84
+23
+38% +$8.32K
STOK icon
1103
Stoke Therapeutics
STOK
$2.11B
$28K ﹤0.01%
835
+20
+2% +$707
ARTL icon
1104
Artelo Biosciences
ARTL
$2.51M
$27K ﹤0.01%
+105
New +$35.9K
BMY icon
1105
Bristol-Myers Squibb
BMY
$132B
$27K ﹤0.01%
+405
New +$26.4K
EXC icon
1106
Exelon
EXC
$47B
$27K ﹤0.01%
+876
New +$28.2K
SO icon
1107
Southern Company
SO
$107B
$27K ﹤0.01%
+460
New +$29.4K
VNDA icon
1108
Vanda Pharmaceuticals
VNDA
$302M
$27K ﹤0.01%
1,265
+20
+2% +$358
NRIX icon
1109
Nurix Therapeutics
NRIX
$2.65B
$26K ﹤0.01%
1,010
+125
+14% +$3.67K
PCVX icon
1110
Vaxcyte
PCVX
$8.64B
$26K ﹤0.01%
1,170
+20
+2% +$409
RPTX
1111
DELISTED
Repare Therapeutics
RPTX
$26K ﹤0.01%
840
+10
+1% +$327
FMTX
1112
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$26K ﹤0.01%
1,080
+70
+7% +$1.88K
CVS icon
1113
CVS Health
CVS
$122B
$25K ﹤0.01%
+300
New +$24.6K
PSNL icon
1114
Personalis
PSNL
$1.51B
$25K ﹤0.01%
1,000
+10
+1% +$229
BNKK
1115
Bonk Inc
BNKK
$8.4M
$25K ﹤0.01%
+397
New +$62K
APD icon
1116
Air Products & Chemicals
APD
$67.6B
$24K ﹤0.01%
+85
New +$25K
CPA icon
1117
Copa Holdings
CPA
$5.8B
$24K ﹤0.01%
+319
New +$25.7K
OCUL icon
1118
Ocular Therapeutix
OCUL
$2.02B
$24K ﹤0.01%
1,735
+35
+2% +$532
PETQ
1119
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$24K ﹤0.01%
645
+75
+13% +$2.99K
ENDP
1120
DELISTED
Endo International plc
ENDP
$24K ﹤0.01%
5,310
+95
+2% +$545
AFMD
1121
DELISTED
Affimed
AFMD
$23K ﹤0.01%
271
+10
+4% +$912
CHRS icon
1122
Coherus Oncology
CHRS
$196M
$23K ﹤0.01%
1,725
+70
+4% +$991
LEGN icon
1123
Legend Biotech
LEGN
$4.01B
$23K ﹤0.01%
570
+30
+6% +$1.02K
NKTX icon
1124
Nkarta
NKTX
$172M
$23K ﹤0.01%
745
+5
+0.7% +$144
PLRX icon
1125
Pliant Therapeutics
PLRX
$65M
$23K ﹤0.01%
815
+15
+2% +$467
43 44
45
46 47

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Penserra Capital Management held 1,445 positions worth $5.51B, up 1.8% from $5.41B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Penserra Capital Management withdrew a net $170M in Q2 2021, closing 112 positions and reducing 341 holdings. Its most notable exit was Just Eat Takeaway.com N.V. American Depositary Shares, an estimated $23.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 30% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Penserra Capital Management opened a new position in ContextLogic worth $28.5M.

  • Penserra Capital Management's largest Q2 2021 buy was ContextLogic: 72,047 shares worth $28.5M.
  • Penserra Capital Management added most to Advanced Micro Devices in Q2 2021, an estimated $53.9M increase.
  • Penserra Capital Management's biggest Q2 2021 reduction was Revolve Group, cutting an estimated $66M.
  • Penserra Capital Management fully exited Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, selling an estimated $23.3M.
  • Penserra Capital Management's ten largest holdings make up 18% of its $5.51B portfolio in Q2 2021.
  • Penserra Capital Management opened 336 new positions and closed 112 in Q2 2021.
  • Penserra Capital Management's portfolio value rose 1.8% quarter-over-quarter to $5.51B.

Based on Penserra Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.